BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//suviendo.com//Fortbildungen//DE
BEGIN:VEVENT
UID:fcba0643-00ab-4e42-9652-038badddf3d0@suviendo.com
DTSTAMP:20260924T074517Z
DTSTART;VALUE=DATE:20261014
DTEND;VALUE=DATE:20261014
SUMMARY:Hybrid - Aroxybutynin and atomoxetine (AD109) for obstructive sleep apnea: a randomized phase 3 trial (SynAIRgy).
LOCATION:Online, Deutschland
DESCRIPTION:https://www.aekno.de/presse/veranstaltungen/detail/114876-Hybrid-Aroxybutynin-and-atomoxetine-AD109-for-obstructive-sleep-apnea-a-randomized-phase-3-trial-SynAIRgy-
URL:https://www.aekno.de/presse/veranstaltungen/detail/114876-Hybrid-Aroxybutynin-and-atomoxetine-AD109-for-obstructive-sleep-apnea-a-randomized-phase-3-trial-SynAIRgy-
END:VEVENT
END:VCALENDAR